Relay Therapeutics, Inc. (RLAY)
18.09
+0.01
(+0.06%)
USD |
NASDAQ |
Nov 13, 16:00
18.10
+0.01
(+0.06%)
Pre-Market: 19:59
Relay Therapeutics Price to Book Value : 4.848 for Nov. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 4.848 |
| November 12, 2026 | 4.846 |
| November 11, 2026 | 5.285 |
| November 10, 2026 | 5.344 |
| November 09, 2026 | 5.465 |
| November 06, 2026 | 4.985 |
| November 05, 2026 | 4.556 |
| November 04, 2026 | 4.832 |
| November 03, 2026 | 4.674 |
| November 02, 2026 | 4.631 |
| October 30, 2026 | 4.918 |
| October 29, 2026 | 5.218 |
| October 28, 2026 | 5.277 |
| October 27, 2026 | 5.049 |
| October 26, 2026 | 4.856 |
| October 23, 2026 | 4.872 |
| October 22, 2026 | 4.915 |
| October 21, 2026 | 4.934 |
| October 20, 2026 | 4.945 |
| October 19, 2026 | 4.580 |
| October 16, 2026 | 4.363 |
| October 15, 2026 | 4.637 |
| October 14, 2026 | 4.572 |
| October 13, 2026 | 4.653 |
| October 12, 2026 | 4.819 |
| Date | Value |
|---|---|
| October 09, 2026 | 4.792 |
| October 08, 2026 | 4.666 |
| October 07, 2026 | 4.811 |
| October 06, 2026 | 5.023 |
| October 05, 2026 | 5.197 |
| October 02, 2026 | 5.082 |
| October 01, 2026 | 4.956 |
| September 30, 2026 | 4.838 |
| September 29, 2026 | 4.508 |
| September 28, 2026 | 4.344 |
| September 25, 2026 | 4.290 |
| September 24, 2026 | 4.353 |
| September 23, 2026 | 4.427 |
| September 22, 2026 | 4.751 |
| September 21, 2026 | 4.466 |
| September 18, 2026 | 4.626 |
| September 17, 2026 | 4.712 |
| September 16, 2026 | 4.626 |
| September 15, 2026 | 4.658 |
| September 14, 2026 | 4.68 |
| September 11, 2026 | 4.633 |
| September 10, 2026 | 4.638 |
| September 09, 2026 | 4.582 |
| September 08, 2026 | 4.692 |
| September 04, 2026 | 4.675 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| SELLAS Life Sciences Group, Inc. | 12.14 |
| TG Therapeutics, Inc. | 17.04 |
| Spyre Therapeutics, Inc. | 10.34 |
| ACADIA Pharmaceuticals, Inc. | 2.335 |
| Alnylam Pharmaceuticals, Inc. | 6.131 |
Price to Book Value Related Metrics
| PS Ratio | 338.76 |
| Price | 18.09 |
| Earnings Yield | -8.35% |
| Market Cap | 3.971B |